Free

Rating summary
1
0
0
0
0

Details

  • Released
  • Updated
  • March 17, 2020
  • February 28, 2024

Features

Metric Pro screenshot #1 for iPhone
Metric Pro screenshot #2 for iPhone
Metric Pro screenshot #3 for iPhone
Metric Pro screenshot #4 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

This app is a registry designed to track the natural history of Medullary Thyroid Cancer (MTC). It aims to understand disease progression and identify patient-reported outcomes to inform treatment decisions and clinical trial design.

Medullary Thyroid Cancer registry
Track disease progression
Identify patient-reported outcomes
Inform treatment decisions
Aid clinical trial design
Show original description

What's New in Metric Pro

1.0.12

February 28, 2024

Fixed notification schedule

Developer apps

FAQ

What is Metric Pro used for?

Metric Pro is a multi-institutional registry designed to describe the natural history of Medullary Thyroid Cancer (MTC). It aims to understand disease progression and identify patient-reported outcomes.

Is Metric Pro free to use?

Yes, Metric Pro is available for free. It does not have any associated costs for users.

What devices does Metric Pro support?

Metric Pro is supported on iPhone, iPad, and iPod devices.

What is the age rating for Metric Pro?

Metric Pro has an age rating of 12+, making it suitable for users aged 12 and above.

How often is Metric Pro updated?

The latest version of Metric Pro was released on February 28, 2024, indicating recent development and maintenance.

What is the user rating for Metric Pro?

Metric Pro has a perfect rating of 5.0 stars from one rating, suggesting a highly positive user experience.

Does Metric Pro integrate with other health apps?

The provided information does not specify integration with other health apps. Its primary function is as a dedicated registry for MTC.

Can Metric Pro be used offline?

The description does not mention offline functionality. As a registry, it likely requires an internet connection for data submission and access.